Clinical trials
Completed Mycobacterium Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2010 | 4 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 5 |
| Centre Hospitalier Universitaire, Amiens | 2 |
| Kevin Winthrop | 2 |
| Manresana de Micobacteriologia, SL | 2 |
| Michael Hoelscher | 2 |
| National Center for Research Resources (NCRR) | 2 |
| National Institutes of Health Clinical Center (CC) | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
| Vanderbilt University | 2 |
| Aaron Diamond AIDS Research Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mycobacterium Infections | 33 |
| Tuberculosis | 16 |
| Bacterial Infections | 9 |
| Tuberculosis, Pulmonary | 6 |
| Mycobacterium Infections, Nontuberculous | 5 |
| Communicable Diseases | 4 |
| Immune System Diseases | 4 |
| Mycobacterium avium-intracellulare Infection | 4 |
| Rare Diseases | 4 |
| Tuberculosis, Multidrug-Resistant | 4 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.